Encapsulated cells producing cytochrome P450

Details Encapsulated cells producing cytochrome P450 Encapsulated cells producing cytochrome P450

2005-05-17

2005-05-17

Fredman, Jeffrey (Department: 1636)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C424S093200, C424S009200, C424S093100, C424S093200, C435S069100, C435S320100, C435S325000, C435S382000, C435S455000, C514S002600, C514S04400A

Reexamination Certificate

active

06893634

ABSTRACT:
The present invention relates to capsules encapsulating cytochrome P450 producing cells and cytochrome P450 producing retroviral packaging cells. Furthermore, the present invention relates to the treatment of cancer or any other relevant disease with said capsules and to the use of said capsules for the preparation of a pharmaceutical composition for said treatment.

REFERENCES:
patent: WO 8911539 (1989-11-01), None
patent: WO 9429437 (1994-12-01), None
patent: WO 9604789 (1996-02-01), None
patent: WO 9607748 (1996-03-01), None
patent: WO 9701357 (1997-01-01), None
patent: WO 9709440 (1997-03-01), None
patent: WO 9735994 (1997-11-01), None
U.S. Appl. No. 08/996,460, filed on Dec. 23, 1997, entitled “Encapsulated Cells Producing Viral Particles”, by Robert Michael Saller, Walter H. Günzburg and Brian Salmons.
Wright, J.E., et al., “Analysis of 4-Hydroxycyclophosphamide in Human Blood”,Analy. Biochem., 224(1) : 154-158 (1995).
Connors, T.A., “The choice of prodrugs for gene directed enzyme prodrug therapy of cancer”,Gene Ther.,(10) : 702-709 (1995).
Salmons, B., et al., “Construction of Retroviral Vectors for Targeted Delivery and Expression of Therapeutic Genes”,Leukemia, 9(Supplement 1) :S53-S60 (1995).
Wei, M.X., et al., “Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene”,Human Gene Ther., 5(8):969-978 (1994).
Chen, S.-H., et al., “Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo”,Proc. Natl. Acad. Sci. USA, 91(8):3054-3057 (1994).
Donato, M.T., et al., “A Microassay for Measuring Cytochrome P450IA1 and P450IIB1 Activities in Intact Human and Rat Hepatocytes Cultured on 96-Well Plates”,Analyt. Biochem., 213(1):29-33 (1993).
Freeman, S.M., et al., “The “Bystander Effect”: Tumor Regression When a Fraction of the Tumor Mass is Genetically Modified”,Can. Res., 53(21):5274-5283 (1993).
Vile, R. G. and Hart, I. R., “Use of Tissue-specific Expression of the Herpes Simplex Virus Thymidine Kinase Gene to Inhibit Growth of Established Murine Melanomas following Direct Intratumoral Injection of DNA”,Can. Res., 53(17):3860-3864 (1993).
Bi, W. L., et al., “In Vitro Evidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSVtkRetroviral Gene Therapy”,Human Gene Ther., 4(6):725-731 (1993).
Ram, Z., “In Situ Retroviral-mediated Gene Transfer for the Treatment of Brain Tumors in Rats”,Can. Res., 53(1):83-88 (1993).
Tiano, H. F., et al., “Retroviral mediated expression of human cytochrom P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)”,Carcinog., 14(7):1421-1427 (1993).
Salmons, B. and Günzburg, w. H., “Targeting of Retroviral Vectors For Gene Therapy”,Human Gene Ther., 4(2):129-141 (1993).
Culver, K. W., “In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors”,Sci., 256:1550-1552 (1992).
Kedzie, K. M., et al., “Molecular Basis for a Functionally Unique Cytochrome P450IIB1 Variant”,J. Biol. Chem., 266(33):22515-22521 (1991).
Kolb, A.F., “Characterization of a Protein that Binds a negative Regulatory Element in the Mammary-Specific Whey Acidic Protein Promoter”,Biochem. Biophys. Res. Comm., 217(3):1045-1052 (1995).
Salmons, B., et al., “Production of Mouse Mammary Tumor Virus upon Transfection of a Recombinant Proviral DNA into Cultured Cells”,Virol., 144:101-114 (1985).
Fujii-Kuriyama, Y., et al., “Primary structure of a cytochrome P-450 Coding nucleotide sequence of phenobarbital-inducible cytochrome P-459 cDNA from rat liver”,Proc. Natl. Acad. Sci. USA, 79:2793-2797 (1982).
Connors, T. A., “Prodrugs in cancer chemotherapy”, Xenobiot., 16(10/11):975-988 (1986).
Connors, T. A. and Whisson, M. E., “Cure of Mice bearing Advanced Plasma Cell Tumours with Aniline Mustard: the Relationship between Glucuronidase Activity and Tumour Sensitivity”,Nature, 210:866-867 (1966).

Affiliated with

Also associated with

Rating

Encapsulated cells producing cytochrome P450 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Encapsulated cells producing cytochrome P450, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encapsulated cells producing cytochrome P450 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3399446